Abeona Therapeutics to Participate in Upcoming Investor Conferences
September 08 2020 - 4:05PM
Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader
in gene and cell therapy, today announced that the Company will
participate in the following upcoming investor conferences.
- João Siffert, M.D., Chief Executive Officer, will conduct
virtual one-on-one meetings with institutional investors at Citi’s
15th Annual BioPharma Virtual Conference on Wednesday, September 9,
2020.
- Dr. Siffert will present at the Wells Fargo Virtual Healthcare
Conference on Thursday, September 10, 2020 at 10:00 a.m. ET. A live
webcast of the presentation will be available on the investor
section of the Abeona Therapeutics website at
www.abeonatherapeutics.com. The webcast replay will be available
within 24 hours of the live presentation and will be accessible for
30 days.
About Abeona Therapeutics Abeona Therapeutics
Inc. is a clinical-stage biopharmaceutical company developing gene
and cell therapies for serious diseases. Abeona’s clinical programs
include EB-101, its autologous, gene-corrected cell therapy for
recessive dystrophic epidermolysis bullosa in Phase 3 development,
as well as ABO-102 and ABO-101, novel AAV-based gene therapies for
Sanfilippo syndrome types A and B (MPS IIIA and MPS IIIB),
respectively, in Phase 1/2 development. The Company’s portfolio of
AAV-based gene therapies also features ABO-201 for CLN3 disease.
Abeona’s novel, next-generation AIM™ capsids have shown potential
to improve tropism profiles for a variety of devastating diseases.
Abeona’s fully functional, gene and cell therapy GMP manufacturing
facility produces EB-101 for the pivotal Phase 3 VIITAL™ study and
is capable of clinical and commercial production of AAV-based gene
therapies. For more information, visit
www.abeonatherapeutics.com.
Investor Contact:Greg Gin VP, Investor
Relations Abeona Therapeutics +1 (646)
813-4709ggin@abeonatherapeutics.com
Media Contact:Scott Santiamo Director,
Corporate Communications Abeona Therapeutics +1 (718) 344-5843
ssantiamo@abeonatherapeutics.com
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Apr 2023 to Apr 2024